Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share (ABVX)
CUSIP: 00370M103
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Ordinary Shares, nominal value Euro 0.01 per share
- Shares outstanding
- 78,459,900
- Total 13F shares
- 56,312,422
- Share change
- +3,845,855
- Total reported value
- $7,607,004,075
- Put/Call ratio
- 65%
- Price per share
- $134.86
- Number of holders
- 247
- Value change
- +$630,821,272
- Number of buys
- 172
- Number of sells
- 74
Quarterly Holders Quick Answers
What is CUSIP 00370M103?
CUSIP 00370M103 identifies ABVX - Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q3 2025
Recent filing periods for CUSIP 00370M103:
Institutional Holders of Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share (ABVX) as of Q4 2025
As of 31 Dec 2025,
Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share (ABVX) was held by
247 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,312,422 shares.
The largest 10 holders included
TCG Crossover Management, LLC, UBS Group AG, Darwin Global Management, Ltd., MORGAN STANLEY, Point72 Asset Management, L.P., Vestal Point Capital, LP, Caligan Partners LP, Paradigm Biocapital Advisors LP, FMR LLC, and Cormorant Asset Management, LP.
This page lists
247
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
165
Q4 2025 holders
247
Holder diff
82
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.